CTMX CytomX Therapeutics, Inc. Stock Quote

CTMX [NASD]

Index	-	P/E	-	EPS (ttm)	-0.71	Insider Own	0.40%	Shs Outstand	62.05M	Perf Week	-3.31%
Market Cap	493.01M	Forward P/E	-	EPS next Y	-2.08	Insider Trans	0.00%	Shs Float	48.42M	Perf Month	-1.04%
Income	-32.90M	PEG	-	EPS next Q	-0.34	Inst Own	64.50%	Short Float	6.87%	Perf Quarter	0.93%
Sales	100.40M	P/S	4.91	EPS this Y	68.40%	Inst Trans	3.74%	Short Ratio	3.57	Perf Half Y	8.26%
Book/sh	1.07	P/B	7.10	EPS next Y	-25.30%	ROA	-8.40%	Target Price	12.56	Perf Year	5.12%
Cash/sh	4.87	P/C	1.56	EPS next 5Y	-0.90%	ROE	-58.10%	52W Range	3.60 - 15.44	Perf YTD	16.03%
Dividend	-	P/FCF	164.34	EPS past 5Y	32.00%	ROI	-69.70%	52W High	-50.78%	Beta	0.61
Dividend %	-	Quick Ratio	3.20	Sales past 5Y	67.10%	Gross Margin	-	52W Low	111.40%	ATR	0.58
Employees	144	Current Ratio	3.20	Sales Q/Q	97.60%	Oper. Margin	-48.40%	RSI (14)	43.72	Volatility	7.36% 7.22%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	59.60%	Profit Margin	-32.80%	Rel Volume	1.01	Prev Close	8.21
Shortable	Yes	LT Debt/Eq	0.00	Earnings	Feb 24 AMC	Payout	-	Avg Volume	931.96K	Price	7.60
Recom	2.30	SMA20	-8.82%	SMA50	-1.83%	SMA200	0.29%	Volume	937,130	Change	-7.43%

Sep-22-20

Downgrade

Guggenheim

Buy → Neutral

Jun-01-20

Downgrade

Jefferies

Buy → Hold

$16 → $10

May-14-20

Reiterated

H.C. Wainwright

Buy

$16 → $12

Mar-24-20

Upgrade

Wedbush

Neutral → Outperform

Mar-04-20

Initiated

Barclays

Equal Weight

Nov-20-19

Initiated

Guggenheim

Buy

Nov-11-19

Downgrade

Wedbush

Outperform → Neutral

$25 → $8

Jun-13-19

Initiated

Mizuho

Buy

May-14-19

Initiated

Cantor Fitzgerald

Overweight

$21

Mar-11-19

Initiated

Barclays

Overweight

$16

Nov-26-18

Initiated

Piper Jaffray

Overweight

$22

Oct-15-18

Initiated

Goldman

Neutral

$21

Sep-13-18

Initiated

H.C. Wainwright

Buy

$32

Jun-01-18

Initiated

SunTrust

Buy

$38

Jan-05-18

Initiated

Citigroup

Buy

$40

Sep-08-17

Initiated

Wedbush

Outperform

$26

Mar-27-17

Initiated

H.C. Wainwright

Buy

$24

Mar-02-17

Initiated

Instinet

Buy

$21

Jan-03-17

Downgrade

Oppenheimer

Outperform → Perform

Nov-02-15

Initiated

Oppenheimer

Outperform

$17

Mar-02-21 12:00PM	CytomX Therapeutics (CTMX) Upgraded to Buy: What Does It Mean for the Stock? Zacks
05:58AM	Moving Average Crossover Alert: CytomX Therapeutics (CTMX) Zacks
Feb-25-21 09:01AM	CytomX Therapeutics, Inc. (CTMX) Q4 2020 Earnings Call Transcript Motley Fool
Feb-24-21 04:15PM	CytomX Therapeutics Announces Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update GlobeNewswire
Feb-23-21 10:25AM	A Preview Of CytomX Therapeutics's Earnings Benzinga -5.65%
Feb-22-21 08:00AM	CytomX Therapeutics to Present at Upcoming March Virtual Investor Conferences GlobeNewswire
Feb-20-21 02:44AM	We're Not Worried About CytomX Therapeutics' (NASDAQ:CTMX) Cash Burn Simply Wall St.
Feb-19-21 08:00AM	CytomX Therapeutics Announces New Employment Inducement Grant GlobeNewswire
Feb-17-21 08:00AM	CytomX Therapeutics to Announce Fourth Quarter and Full Year 2020 Financial Results on February 24, 2021 GlobeNewswire
Feb-04-21 08:00AM	CytomX Therapeutics to Present at Guggenheim Healthcare Talks 2021 Oncology Day GlobeNewswire
Feb-03-21 08:19AM	UPDATE - CytomX Therapeutics Announces Full Exercise of Underwriters Option to Purchase Additional Shares GlobeNewswire
08:00AM	CytomX Therapeutics Announces Full Exercise of Underwriters Option to Purchase Additional Shares GlobeNewswire
Jan-26-21 08:00AM	CytomX Therapeutics Announces Closing of Public Offering of Common Stock GlobeNewswire
Jan-20-21 09:50PM	CytomX Therapeutics Announces Pricing of $100 Million Public Offering of Common Stock GlobeNewswire
Jan-19-21 04:35PM	CytomX Therapeutics Announces Proposed Public Offering of Common Stock GlobeNewswire +6.94%
08:00AM	CytomX Therapeutics Announces New Employment Inducement Grants GlobeNewswire
Jan-07-21 08:00AM	CytomX Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference GlobeNewswire
Dec-24-20 10:10AM	Is CTMX A Good Stock To Buy According To Hedge Funds? Insider Monkey
Dec-22-20 04:05PM	CytomX Therapeutics Appoints Dr. Mani Mohindru to Board of Directors GlobeNewswire
12:58AM	Would Shareholders Who Purchased CytomX Therapeutics' (NASDAQ:CTMX) Stock Three Years Be Happy With The Share price Today? Simply Wall St.
Dec-03-20 08:00AM	CytomX Therapeutics to Present Updates on CX-2009 at 2020 San Antonio Breast Cancer Symposium GlobeNewswire
Nov-11-20 04:01PM	CytomX Therapeutics to Present at Upcoming Investor Conferences GlobeNewswire
Nov-07-20 08:40AM	CytomX Therapeutics, Inc. (NASDAQ:CTMX) Just Released Its Third-Quarter Earnings: Here's What Analysts Think Simply Wall St.
Nov-06-20 03:01PM	CytomX Therapeutics, Inc. (CTMX) Q3 2020 Earnings Call Transcript Motley Fool
Nov-05-20 08:00PM	CytomX Therapeutics (CTMX) Reports Q3 Loss, Tops Revenue Estimates Zacks
04:15PM	CytomX Therapeutics, Inc. to Host Earnings Call ACCESSWIRE
04:15PM	CytomX Therapeutics Announces Third Quarter 2020 Financial Results and Provides Business Update GlobeNewswire
08:00AM	CytomX Therapeutics Announces Treatment of First Patient in Phase 2 Expansion Study of CX-2029, an Anti-CD71 Probody Drug Conjugate GlobeNewswire
Oct-29-20 12:34PM	CytomX Therapeutics (CTMX) May Report Negative Earnings: Know the Trend Ahead of Q3 Release Zacks
08:00AM	CytomX Therapeutics to Announce Third Quarter 2020 Financial Results GlobeNewswire
Oct-09-20 08:32AM	What We Learned About CytomX Therapeutics' (NASDAQ:CTMX) CEO Compensation Simply Wall St.
Oct-06-20 05:41PM	Hedge Funds Are Bullish On CytomX Therapeutics, Inc. (CTMX) Insider Monkey
04:10PM	CytomX Therapeutics Announces the Planned Retirement of Chief Scientific Officer, W. Michael Kavanaugh, M.D. GlobeNewswire
Sep-18-20 08:00AM	CytomX Therapeutics Announces New Employment Inducement Grants GlobeNewswire
Sep-02-20 08:00AM	CytomX Therapeutics to Participate in Upcoming Healthcare Conferences GlobeNewswire
Aug-24-20 09:23AM	What Type Of Shareholders Make Up CytomX Therapeutics, Inc.'s (NASDAQ:CTMX) Share Registry? Simply Wall St.
Aug-06-20 04:15PM	CytomX Therapeutics Announces Second Quarter 2020 Financial Results and Provides Business Update GlobeNewswire
Aug-04-20 08:00AM	CytomX Therapeutics to Participate in the 2020 Wedbush PacGrow Healthcare Conference GlobeNewswire
Jul-30-20 12:33PM	CytomX Therapeutics (CTMX) Earnings Expected to Grow: Should You Buy? Zacks
Jul-28-20 08:00AM	CytomX Therapeutics to Announce Second Quarter 2020 Financial Results GlobeNewswire -6.57%
Jul-20-20 04:03PM	Did Hedge Funds Make The Right Call On CytomX Therapeutics, Inc. (CTMX) ? Insider Monkey
01:00PM	CLASS ACTION UPDATE for CTMX, GEO and JCOM: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
12:40PM	FINAL DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against CytomX Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
11:40AM	SHAREHOLDER ALERT: CTMX ENPH GEO: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
11:00AM	CTMX Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against CytomX Therapeutics, Inc. and Lead Plaintiff Deadline: July 20, 2020 Newsfile
09:48AM	DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against CytomX Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile
08:50AM	LAWSUITS FILED AGAINST CTMX, PPC and BKD - JAKUBOWITZ LAW PURSUES SHAREHOLDERS CLAIMS ACCESSWIRE
07:30AM	SHAREHOLDER ALERT: CTMX PPC JCOM: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
06:20AM	SHAREHOLDER ALERT: CTMX PPC WRCDF: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
12:20AM	FINAL DEADLINE TOMORROW: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against CytomX Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
Jul-18-20 03:45PM	MONDAY DEADLINE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against CytomX Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
01:35PM	FINAL MONDAY DEADLINE: ROSEN, A LEADING, LONGSTANDING, AND TOP RANKED FIRM, Reminds CytomX Therapeutics, Inc. Investors TO CONTACT FIRM BEFORE Important Monday JULY 20 Deadline in Securities Class Action - CTMX ACCESSWIRE
Jul-17-20 11:24PM	Lead Plaintiff Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In CytomX Therapeutics, Inc. To Contact The Firm Newsfile
01:30PM	CLASS ACTION UPDATE for CTMX, SRNE and BAYRY: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
01:00PM	CTMX Upcoming Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against CytomX Therapeutics, Inc. and Lead Plaintiff Deadline: July 20, 2020 GlobeNewswire
12:32PM	DEADLINE MONDAY ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against CytomX Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile
11:50AM	The Gross Law Firm Announces Class Actions on Behalf of Shareholders of CTMX, ENDP and CSPR ACCESSWIRE
11:21AM	CTMX FINAL DEADLINE: ROSEN, A LEADING, LONGSTANDING, AND TOP RANKED FIRM, Reminds CytomX Therapeutics, Inc. Investors of Important Monday Deadline in Securities Class Action CTMX GlobeNewswire
Jul-16-20 03:45PM	The Gross Law Firm Announces Class Actions on Behalf of Shareholders of CTMX, ENDP and CEMI ACCESSWIRE
01:55PM	FINAL DEADLINE JULY 20: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against CytomX Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
01:53PM	CTMX ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of July 20, 2020 in the Class Action Filed on Behalf of CytomX Therapeutics, Inc. Limited Shareholders Newsfile
12:12PM	CTMX Upcoming Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against CytomX Therapeutics, Inc. and Lead Plaintiff Deadline: July 20, 2020 ACCESSWIRE
12:10PM	The Gross Law Firm Announces Class Actions on Behalf of Shareholders of CTMX, SRNE and BKD ACCESSWIRE
11:30AM	The Gross Law Firm Announces Class Actions on Behalf of Shareholders of CTMX, SRNE and IDEX ACCESSWIRE
10:11AM	CTMX Shareholder Update: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against CytomX Therapeutics, Inc. and Lead Plaintiff Deadline: July 20, 2020 ACCESSWIRE
09:52AM	SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of CytomX Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 20, 2020 - CTMX Newsfile
09:39AM	MONDAY DEADLINE NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against CytomX Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile
08:00AM	CytomX Investors: Last Days to Seek Participation in Class Action as Lead Plaintiff GlobeNewswire
Jul-15-20 09:55AM	The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of R, CTMX and JCOM ACCESSWIRE
09:25AM	MONDAY DEADLINE REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against CytomX Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile
Jul-14-20 12:23PM	SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of CytomX Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 20, 2020 - CTMX Newsfile
11:00AM	CTMX Upcoming Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against CytomX Therapeutics, Inc. and Lead Plaintiff Deadline: July 20, 2020 Business Wire
10:24AM	Lead Plaintiff Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In CytomX Therapeutics, Inc. To Contact The Firm Newsfile
09:24AM	MONDAY DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against CytomX Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile
03:49AM	Edited Transcript of CTMX earnings conference call or presentation 7-May-20 9:00pm GMT Thomson Reuters StreetEvents
Jul-13-20 10:15AM	The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of CONN, CTMX and KL ACCESSWIRE
09:50AM	7-DAY DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against CytomX Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile
01:30AM	SHAREHOLDER ALERT: CTMX JCOM WRCDF: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
Jul-12-20 11:00AM	CytomX Investors: Last Days to Seek Participation in Class Action as Lead Plaintiff GlobeNewswire
Jul-10-20 11:47PM	Lead Plaintiff Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In CytomX Therapeutics, Inc. To Contact The Firm Newsfile
06:57PM	SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of CytomX Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 20, 2020 - CTMX Newsfile
05:30PM	ROSEN, A LONGSTANDING AND TOP RANKED FIRM, Reminds CytomX Therapeutics, Inc. Investors of Important Deadline in Securities Class Action - CTMX PR Newswire
01:30PM	The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of CTMX, PPC and WRCDF ACCESSWIRE
01:00PM	CTMX Investor Update: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against CytomX Therapeutics, Inc. and Lead Plaintiff Deadline: July 20, 2020 GlobeNewswire
11:34AM	Here's Why We're Watching CytomX Therapeutics's (NASDAQ:CTMX) Cash Burn Situation Simply Wall St.
Jul-09-20 04:20PM	Lawsuits Filed Against CONN, CTMX and SRNE - Jakubowitz Law Pursues Shareholders Claims ACCESSWIRE
03:15PM	SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against CytomX Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
Jul-08-20 06:50PM	LAWSUITS FILED AGAINST R, CTMX and CLNY - Jakubowitz Law Pursues Shareholders Claims ACCESSWIRE
01:50PM	The Gross Law Firm Announces Class Actions on Behalf of Shareholders of CONN, CTMX and CCL ACCESSWIRE
01:15PM	Lead Plaintiff Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In CytomX Therapeutics, Inc. To Contact The Firm Newsfile
01:10PM	IMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against CytomX Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
Jul-07-20 05:30PM	The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of CTMX, IDEX and BKD ACCESSWIRE
04:51PM	ROSEN, GLOBAL INVESTOR COUNSEL, Reminds CytomX Therapeutics, Inc. Investors of Important Deadline in Securities Class Action - CTMX PR Newswire
Jul-06-20 11:00PM	The Gross Law Firm Announces Class Actions on Behalf of Shareholders of R, CTMX and WFC ACCESSWIRE
09:10PM	SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against CytomX Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
01:40PM	CLASS ACTION UPDATE for R, CTMX and ENPH: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
12:58PM	CTMX Investor Update: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against CytomX Therapeutics, Inc. and Lead Plaintiff Deadline: July 20, 2020 ACCESSWIRE
01:30AM	The Gross Law Firm Announces Class Actions on Behalf of Shareholders of R, CTMX and FSCT ACCESSWIRE
Jul-03-20 02:55PM	SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in CytomX Therapeutics Inc. of Class Action Lawsuit and Upcoming Deadline - CTMX ACCESSWIRE
11:19AM	Lead Plaintiff Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In CytomX Therapeutics, Inc. To Contact The Firm Newsfile

CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops a novel class of investigational antibody therapeutics based on its Probody technology platform for the treatment of cancer. Its product candidates in clinical stage include CX-072, a Probody therapeutic targeting programmed cell death ligand 1 immuno-oncology target; CX-2009, a Probody drug conjugate (PDC) against CD166 novel drug target; BMS-986249, a CTLA-4 Probody therapeutic drug for the treatment of metastatic melanoma; CX-2029, a PDC targeting CD71 for solid tumors; and BMS-986288, an anti-CTLA-4 Probody drug for solid tumors. The company has strategic collaborations with AbbVie Ireland Unlimited Company, Amgen, Inc., Bristol-Myers Squibb Company, ImmunoGen, Inc., Pfizer Inc., and Astellas Pharma Inc. to develop Probody therapeutics. CytomX Therapeutics, Inc. was founded in 2008 and is headquartered in South San Francisco, California.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
McCarthy Sean A.	President and CEO	Dec 23	Option Exercise	1.13	100,000	113,390	206,894	Dec 28 07:52 PM
McCarthy Sean A.	President and CEO	Sep 21	Option Exercise	6.61	20,500	135,601	105,964	Sep 23 04:53 PM
McCarthy Sean A.	President and CEO	May 12	Option Exercise	1.13	36,000	40,820	120,306	May 14 04:31 PM
McCarthy Sean A.	President and CEO	May 12	Sale	15.00	36,000	540,000	84,306	May 14 04:31 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience